Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidrun Moll

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Infection and Immunity|January 24, 2006
Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cellsUlrich Körner, Veronika Fuss, Jutta Steigerwald, et al.
Immunobiology|August 17, 2002
The course of Leishmania major infection in mice lacking granzyme-mediated mechanismsVeronika Eisert, Uwe Münster, Markus M Simon, et al.
Immunology|August 3, 2010
Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania majorKatharina A Remer, Bianca Roeger, Christine Hambrecht, et al.
Clinical and Diagnostic Laboratory Immunology|May 3, 2002
Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Mycobacterium bovis BCG from the lungs of miceKlaus J Erb, Claudia Trujillo, Mike Fugate, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DCJosé R Ramírez-Pineda, Anja Fröhlich, Christof Berberich, et al.
Protist|January 24, 2009
Meeting Report IFoLeish-2008: current status and future challenges in Leishmania Research and LeishmaniasisStefan Zimmermann, Heidrun Moll, Werner Solbach, et al.
Molecules (Basel, Switzerland)|April 4, 2015
Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivativeJan Glaser, Martina Schultheis, Heidrun Moll, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activityAlicia Ponte-Sucre, Radim Vicik, Martina Schultheis, et al.
European Journal of Immunology|August 21, 2007
Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in miceKatharina A Remer, Calin Apetrei, Tobias Schwarz, et al.
Plos Neglected Tropical Diseases|July 18, 2012
Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c miceAnita Masic, Ramona Hurdayal, Natalie E Nieuwenhuizen, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Infection and Immunity|January 24, 2006
Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cellsUlrich Körner, Veronika Fuss, Jutta Steigerwald, et al.
Immunobiology|August 17, 2002
The course of Leishmania major infection in mice lacking granzyme-mediated mechanismsVeronika Eisert, Uwe Münster, Markus M Simon, et al.
Immunology|August 3, 2010
Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania majorKatharina A Remer, Bianca Roeger, Christine Hambrecht, et al.
Clinical and Diagnostic Laboratory Immunology|May 3, 2002
Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Mycobacterium bovis BCG from the lungs of miceKlaus J Erb, Claudia Trujillo, Mike Fugate, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DCJosé R Ramírez-Pineda, Anja Fröhlich, Christof Berberich, et al.
Protist|January 24, 2009
Meeting Report IFoLeish-2008: current status and future challenges in Leishmania Research and LeishmaniasisStefan Zimmermann, Heidrun Moll, Werner Solbach, et al.
Molecules (Basel, Switzerland)|April 4, 2015
Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivativeJan Glaser, Martina Schultheis, Heidrun Moll, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activityAlicia Ponte-Sucre, Radim Vicik, Martina Schultheis, et al.
European Journal of Immunology|August 21, 2007
Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in miceKatharina A Remer, Calin Apetrei, Tobias Schwarz, et al.
Plos Neglected Tropical Diseases|July 18, 2012
Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c miceAnita Masic, Ramona Hurdayal, Natalie E Nieuwenhuizen, et al.
Pageof 5